Publication | Open Access
M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord.
158
Citations
22
References
1991
Year
Locus CoeruleusPeptide SciencePharmacotherapySpinal Flexor ReflexExperimental PharmacologySocial SciencesMolecular PharmacologyNeurochemistryMolecular NeuroscienceBiochemistryG Protein-coupled ReceptorHigh-affinity Chimeric PeptideNeuropharmacologyGal-induced HyperpolarizationCell BiologyPharmacologySynaptic PlasticityNeuropeptide ReceptorPeptide TherapeuticNeuroscienceMolecular NeurobiologyMedicineDrug DiscoveryNeuropeptides
The 20-amino acid peptide M-15 binds with high affinity (IC50 approximately 0.1 nM) to 125I-labeled galanin (125I-GAL) binding sites in membranes from the ventral hippocampus, midbrain, and rat spinal cord. Receptor autoradiographic studies show that M-15 can displace 125I-GAL from all labeled sites. M-15 acts as a reversible high-affinity antagonist in blocking the inhibitory effects of GAL on the evoked release of acetylcholine in vivo in the hippocampus and on the GAL-induced hyperpolarization of locus coeruleus neurons in slices. M-15 also blocks the facilitatory effects of GAL on the spinal flexor reflex. Thus, the chimeric peptide M-15 [GAL-(1-13)-substance P-(5-11)amide] represents the first antagonist to the neuronal actions of GAL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1